Forte Biosciences, Inc. (FBRX) NASDAQ
17.74
-1.5(-7.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
17.74
-1.5(-7.80%)
Currency In USD
Address
3060 Pegasus Park Drive
Dallas, TX 75247
United States of America (the)
Phone
310 618 6994
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
April 13, 2017
| Name | Title | Pay | Year Born |
| Paul A. Wagner | Chief Executive Officer, President & Chairman | 1.41M | 1970 |
| Barbara K. Finck | Acting Senior Medical Clinician & Director | 600,000 | 1947 |
| Antony A. Riley | Chief Financial Officer | 632,953 | 1967 |
| Christopher Roenfeldt | Chief Operating Officer | 0 | N/A |
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.